Report Detail
COVID-19 Impact on Global Neuroprotective Agents Market Insights, Forecast to 2026
- RnM3985157 |
- 03 June, 2020 |
- Global |
- 116 Pages |
- QYResearch |
- Pharma & Healthcare
Neuroprotective agents are medications that can alter the course of metabolic events after the onset of ischemia and therefore have the potential to reduce stroke damage.
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Neuroprotective Agents market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Neuroprotective Agents industry.
Based on our recent survey, we have several different scenarios about the Neuroprotective Agents YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ xx million in 2019. The market size of Neuroprotective Agents will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Neuroprotective Agents market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Neuroprotective Agents market in terms of both revenue and volume.
Players, stakeholders, and other participants in the global Neuroprotective Agents market will be able to gain the upper hand as they use the report as a powerful resource. For this version of the report, the segmental analysis focuses on sales (volume), revenue and forecast by each application segment in terms of sales and revenue and forecast by each type segment in terms of revenue for the period 2015-2026.
Sales and Pricing Analyses
Readers are provided with deeper sales analysis and pricing analysis for the global Neuroprotective Agents market. As part of sales analysis, the report offers accurate statistics and figures for sales and revenue by region, by each type segment for the period 2015-2026.
In the pricing analysis section of the report, readers are provided with validated statistics and figures for the price by players and price by region for the period 2015-2020 and price by each type segment for the period 2015-2020.
Regional and Country-level Analysis
The report offers an exhaustive geographical analysis of the global Neuroprotective Agents market, covering important regions, viz, North America, Europe, China and Japan. It also covers key countries (regions), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by each application segment in terms of sales for the period 2015-2026.
Competition Analysis
In the competitive analysis section of the report, leading as well as prominent players of the global Neuroprotective Agents market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on sales by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Neuroprotective Agents market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Neuroprotective Agents market.
The following manufacturers are covered in this report:
Genervon Biopharmaceuticals
NeuroVive Pharmaceutical
Ceregene
Neuren Pharmaceuticals
Allon Therapeutics
...
Neuroprotective Agents Breakdown Data by Type
Cerebrovascular Diseases
Neurodegenerative Disorders
Ophthalmic Diseases
Traumatic CNS Injuries
Neuroprotective Agents Breakdown Data by Application
Hospitals
Clinics
Others
1 Study Coverage
- 1.1 Neuroprotective Agents Product Introduction
- 1.2 Market Segments
- 1.3 Key Neuroprotective Agents Manufacturers Covered: Ranking by Revenue
- 1.4 Market by Type
- 1.4.1 Global Neuroprotective Agents Market Size Growth Rate by Type
- 1.4.2 Cerebrovascular Diseases
- 1.4.3 Neurodegenerative Disorders
- 1.4.4 Ophthalmic Diseases
- 1.4.5 Traumatic CNS Injuries
- 1.5 Market by Application
- 1.5.1 Global Neuroprotective Agents Market Size Growth Rate by Application
- 1.5.2 Hospitals
- 1.5.3 Clinics
- 1.5.4 Others
- 1.6 Coronavirus Disease 2019 (Covid-19): Neuroprotective Agents Industry Impact
- 1.6.1 How the Covid-19 is Affecting the Neuroprotective Agents Industry
- 1.6.1.1 Neuroprotective Agents Business Impact Assessment - Covid-19
- 1.6.1.2 Supply Chain Challenges
- 1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
- 1.6.2 Market Trends and Neuroprotective Agents Potential Opportunities in the COVID-19 Landscape
- 1.6.3 Measures / Proposal against Covid-19
- 1.6.3.1 Government Measures to Combat Covid-19 Impact
- 1.6.3.2 Proposal for Neuroprotective Agents Players to Combat Covid-19 Impact
- 1.6.1 How the Covid-19 is Affecting the Neuroprotective Agents Industry
- 1.7 Study Objectives
- 1.8 Years Considered
2 Executive Summary
- 2.1 Global Neuroprotective Agents Market Size Estimates and Forecasts
- 2.1.1 Global Neuroprotective Agents Revenue 2015-2026
- 2.1.2 Global Neuroprotective Agents Sales 2015-2026
- 2.2 Neuroprotective Agents Market Size by Region: 2020 Versus 2026
- 2.2.1 Global Neuroprotective Agents Retrospective Market Scenario in Sales by Region: 2015-2020
- 2.2.2 Global Neuroprotective Agents Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Neuroprotective Agents Competitor Landscape by Players
- 3.1 Neuroprotective Agents Sales by Manufacturers
- 3.1.1 Neuroprotective Agents Sales by Manufacturers (2015-2020)
- 3.1.2 Neuroprotective Agents Sales Market Share by Manufacturers (2015-2020)
- 3.2 Neuroprotective Agents Revenue by Manufacturers
- 3.2.1 Neuroprotective Agents Revenue by Manufacturers (2015-2020)
- 3.2.2 Neuroprotective Agents Revenue Share by Manufacturers (2015-2020)
- 3.2.3 Global Neuroprotective Agents Market Concentration Ratio (CR5 and HHI) (2015-2020)
- 3.2.4 Global Top 10 and Top 5 Companies by Neuroprotective Agents Revenue in 2019
- 3.2.5 Global Neuroprotective Agents Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
- 3.3 Neuroprotective Agents Price by Manufacturers
- 3.4 Neuroprotective Agents Manufacturing Base Distribution, Product Types
- 3.4.1 Neuroprotective Agents Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Neuroprotective Agents Product Type
- 3.4.3 Date of International Manufacturers Enter into Neuroprotective Agents Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2015-2026)
- 4.1 Global Neuroprotective Agents Market Size by Type (2015-2020)
- 4.1.1 Global Neuroprotective Agents Sales by Type (2015-2020)
- 4.1.2 Global Neuroprotective Agents Revenue by Type (2015-2020)
- 4.1.3 Neuroprotective Agents Average Selling Price (ASP) by Type (2015-2026)
- 4.2 Global Neuroprotective Agents Market Size Forecast by Type (2021-2026)
- 4.2.1 Global Neuroprotective Agents Sales Forecast by Type (2021-2026)
- 4.2.2 Global Neuroprotective Agents Revenue Forecast by Type (2021-2026)
- 4.2.3 Neuroprotective Agents Average Selling Price (ASP) Forecast by Type (2021-2026)
- 4.3 Global Neuroprotective Agents Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Breakdown Data by Application (2015-2026)
- 5.1 Global Neuroprotective Agents Market Size by Application (2015-2020)
- 5.1.1 Global Neuroprotective Agents Sales by Application (2015-2020)
- 5.1.2 Global Neuroprotective Agents Revenue by Application (2015-2020)
- 5.1.3 Neuroprotective Agents Price by Application (2015-2020)
- 5.2 Neuroprotective Agents Market Size Forecast by Application (2021-2026)
- 5.2.1 Global Neuroprotective Agents Sales Forecast by Application (2021-2026)
- 5.2.2 Global Neuroprotective Agents Revenue Forecast by Application (2021-2026)
- 5.2.3 Global Neuroprotective Agents Price Forecast by Application (2021-2026)
6 North America
- 6.1 North America Neuroprotective Agents by Country
- 6.1.1 North America Neuroprotective Agents Sales by Country
- 6.1.2 North America Neuroprotective Agents Revenue by Country
- 6.1.3 U.S.
- 6.1.4 Canada
- 6.2 North America Neuroprotective Agents Market Facts & Figures by Type
- 6.3 North America Neuroprotective Agents Market Facts & Figures by Application
7 Europe
- 7.1 Europe Neuroprotective Agents by Country
- 7.1.1 Europe Neuroprotective Agents Sales by Country
- 7.1.2 Europe Neuroprotective Agents Revenue by Country
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 U.K.
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Neuroprotective Agents Market Facts & Figures by Type
- 7.3 Europe Neuroprotective Agents Market Facts & Figures by Application
8 Asia Pacific
- 8.1 Asia Pacific Neuroprotective Agents by Region
- 8.1.1 Asia Pacific Neuroprotective Agents Sales by Region
- 8.1.2 Asia Pacific Neuroprotective Agents Revenue by Region
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 South Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Taiwan
- 8.1.9 Indonesia
- 8.1.10 Thailand
- 8.1.11 Malaysia
- 8.1.12 Philippines
- 8.1.13 Vietnam
- 8.2 Asia Pacific Neuroprotective Agents Market Facts & Figures by Type
- 8.3 Asia Pacific Neuroprotective Agents Market Facts & Figures by Application
9 Latin America
- 9.1 Latin America Neuroprotective Agents by Country
- 9.1.1 Latin America Neuroprotective Agents Sales by Country
- 9.1.2 Latin America Neuroprotective Agents Revenue by Country
- 9.1.3 Mexico
- 9.1.4 Brazil
- 9.1.5 Argentina
- 9.2 Central & South America Neuroprotective Agents Market Facts & Figures by Type
- 9.3 Central & South America Neuroprotective Agents Market Facts & Figures by Application
10 Middle East and Africa
- 10.1 Middle East and Africa Neuroprotective Agents by Country
- 10.1.1 Middle East and Africa Neuroprotective Agents Sales by Country
- 10.1.2 Middle East and Africa Neuroprotective Agents Revenue by Country
- 10.1.3 Turkey
- 10.1.4 Saudi Arabia
- 10.1.5 U.A.E
- 10.2 Middle East and Africa Neuroprotective Agents Market Facts & Figures by Type
- 10.3 Middle East and Africa Neuroprotective Agents Market Facts & Figures by Application
11 Company Profiles
- 11.1 Genervon Biopharmaceuticals
- 11.1.1 Genervon Biopharmaceuticals Corporation Information
- 11.1.2 Genervon Biopharmaceuticals Description, Business Overview and Total Revenue
- 11.1.3 Genervon Biopharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
- 11.1.4 Genervon Biopharmaceuticals Neuroprotective Agents Products Offered
- 11.1.5 Genervon Biopharmaceuticals Recent Development
- 11.2 NeuroVive Pharmaceutical
- 11.2.1 NeuroVive Pharmaceutical Corporation Information
- 11.2.2 NeuroVive Pharmaceutical Description, Business Overview and Total Revenue
- 11.2.3 NeuroVive Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
- 11.2.4 NeuroVive Pharmaceutical Neuroprotective Agents Products Offered
- 11.2.5 NeuroVive Pharmaceutical Recent Development
- 11.3 Ceregene
- 11.3.1 Ceregene Corporation Information
- 11.3.2 Ceregene Description, Business Overview and Total Revenue
- 11.3.3 Ceregene Sales, Revenue and Gross Margin (2015-2020)
- 11.3.4 Ceregene Neuroprotective Agents Products Offered
- 11.3.5 Ceregene Recent Development
- 11.4 Neuren Pharmaceuticals
- 11.4.1 Neuren Pharmaceuticals Corporation Information
- 11.4.2 Neuren Pharmaceuticals Description, Business Overview and Total Revenue
- 11.4.3 Neuren Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
- 11.4.4 Neuren Pharmaceuticals Neuroprotective Agents Products Offered
- 11.4.5 Neuren Pharmaceuticals Recent Development
- 11.5 Allon Therapeutics
- 11.5.1 Allon Therapeutics Corporation Information
- 11.5.2 Allon Therapeutics Description, Business Overview and Total Revenue
- 11.5.3 Allon Therapeutics Sales, Revenue and Gross Margin (2015-2020)
- 11.5.4 Allon Therapeutics Neuroprotective Agents Products Offered
- 11.5.5 Allon Therapeutics Recent Development
- 11.1 Genervon Biopharmaceuticals
- 11.1.1 Genervon Biopharmaceuticals Corporation Information
- 11.1.2 Genervon Biopharmaceuticals Description, Business Overview and Total Revenue
- 11.1.3 Genervon Biopharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
- 11.1.4 Genervon Biopharmaceuticals Neuroprotective Agents Products Offered
- 11.1.5 Genervon Biopharmaceuticals Recent Development
12 Future Forecast by Regions (Countries) (2021-2026)
- 12.1 Neuroprotective Agents Market Estimates and Projections by Region
- 12.1.1 Global Neuroprotective Agents Sales Forecast by Regions 2021-2026
- 12.1.2 Global Neuroprotective Agents Revenue Forecast by Regions 2021-2026
- 12.2 North America Neuroprotective Agents Market Size Forecast (2021-2026)
- 12.2.1 North America: Neuroprotective Agents Sales Forecast (2021-2026)
- 12.2.2 North America: Neuroprotective Agents Revenue Forecast (2021-2026)
- 12.2.3 North America: Neuroprotective Agents Market Size Forecast by Country (2021-2026)
- 12.3 Europe Neuroprotective Agents Market Size Forecast (2021-2026)
- 12.3.1 Europe: Neuroprotective Agents Sales Forecast (2021-2026)
- 12.3.2 Europe: Neuroprotective Agents Revenue Forecast (2021-2026)
- 12.3.3 Europe: Neuroprotective Agents Market Size Forecast by Country (2021-2026)
- 12.4 Asia Pacific Neuroprotective Agents Market Size Forecast (2021-2026)
- 12.4.1 Asia Pacific: Neuroprotective Agents Sales Forecast (2021-2026)
- 12.4.2 Asia Pacific: Neuroprotective Agents Revenue Forecast (2021-2026)
- 12.4.3 Asia Pacific: Neuroprotective Agents Market Size Forecast by Region (2021-2026)
- 12.5 Latin America Neuroprotective Agents Market Size Forecast (2021-2026)
- 12.5.1 Latin America: Neuroprotective Agents Sales Forecast (2021-2026)
- 12.5.2 Latin America: Neuroprotective Agents Revenue Forecast (2021-2026)
- 12.5.3 Latin America: Neuroprotective Agents Market Size Forecast by Country (2021-2026)
- 12.6 Middle East and Africa Neuroprotective Agents Market Size Forecast (2021-2026)
- 12.6.1 Middle East and Africa: Neuroprotective Agents Sales Forecast (2021-2026)
- 12.6.2 Middle East and Africa: Neuroprotective Agents Revenue Forecast (2021-2026)
- 12.6.3 Middle East and Africa: Neuroprotective Agents Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Porter’s Five Forces Analysis
- 13.5 Primary Interviews with Key Neuroprotective Agents Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Neuroprotective Agents Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
Summary:
Get latest Market Research Reports on COVID-19 Impact on Global Neuroprotective Agents. Industry analysis & Market Report on COVID-19 Impact on Global Neuroprotective Agents is a syndicated market report, published as COVID-19 Impact on Global Neuroprotective Agents Market Insights, Forecast to 2026. It is complete Research Study and Industry Analysis of COVID-19 Impact on Global Neuroprotective Agents market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
